Buy $TLRY - NRPicks 14 Mar
Tilray, Inc. is dedicated to the research, cultivation, processing and distribution of medical cannabis. The company offers its products to patients, doctors, clinics, pharmacies, governments and hospitals.
The Ministry of Health and the New Zealand Medicinal Cannabis Agency grant Tilray the first approval under the new Medicinal Cannabis Plan to launch medicinal cannabis products across the country, which will undoubtedly have a major impact on revenue of the company.
During the week, most sectors showed a recovery, however, the marijuana companies had a controlled upside and this is likely to continue. We consider that Tilray is in the middle of its journey.
Technical:
- Average RSI levels
- Buying force 143M buying volume last week.
- Bounce on MA100
The Ministry of Health and the New Zealand Medicinal Cannabis Agency grant Tilray the first approval under the new Medicinal Cannabis Plan to launch medicinal cannabis products across the country, which will undoubtedly have a major impact on revenue of the company.
During the week, most sectors showed a recovery, however, the marijuana companies had a controlled upside and this is likely to continue. We consider that Tilray is in the middle of its journey.
Technical:
- Average RSI levels
- Buying force 143M buying volume last week.
- Bounce on MA100
Trade fechado: stop atingido
23 Mar
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.